Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 323
Healthy volunteers: no

Brief summary:
This trial is conducted in Asia, Europe, South America, and the United States of America (USA).

The aim of the trial is to investigate efficacy and safety of FIAsp in a basal-bolus regimen versus basal insulin therapy, both in combination with metformin in adult subjects with type 2 diabetes.

Detailed description:

Arms:
arm 1: Subjects will receive FIAsp combined with their pre-trial basal insulin (insulin human, insulin detemir or insulin glargine) treatment in combination with their pre-trial metformin. arm 2: Subjects will continue their pre-trial basal insulin (insulin human, insulin detemir or insulin glargine) treatment in combination with their pre-trial metformin.

Interventions: intervention 1: Faster-acting insulin aspart intervention 2: basal insulin
Intervention descriptions: intervention 1: Administrated subcutaneously (s.c., under the skin) at each main meal. intervention 2: Administrated subcutaneously (s.c., under the skin) once daily.

Protocol document: